Eliquis Regulatory Post Marketing Surveillance
NCT01885598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3335
Last updated 2017-10-31
Summary
The primary objective of this study is to examine the safety profile of Eliquis in Korean nonvalvular atrial fibrillation patients.
Conditions
- NonValvular Atrial Fibrillation
Interventions
- DRUG
-
Apixaban
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-10
- Primary Completion
- 2017-09-29
- Completion
- 2017-09-29
Countries
- South Korea
Study Locations
More Related Trials
-
Apixaban Dose Reduction in Patients With Elevated Drug Levels
NCT02809469 ·Status: UNKNOWN ·Phase: PHASE2
-
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
NCT00412984 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient
NCT05773222 ·Status: ACTIVE_NOT_RECRUITING
-
Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
NCT02100228 ·Status: COMPLETED ·Phase: PHASE4
-
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
NCT01938248 ·Status: COMPLETED ·Phase: PHASE4
-
Therapy With New Oral Anticoagulants
NCT02222090 ·Status: UNKNOWN
-
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
NCT04586972 ·Status: COMPLETED
-
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
NCT03136510 ·Status: TERMINATED ·Phase: NA
-
Prediction of the COBRRA AF Anticoagulant Trial in Healthcare Claims Data
NCT05256797 ·Status: COMPLETED
-
Assessment of The Effect of Apixaban in AF
NCT03199521 ·Status: COMPLETED
-
Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
NCT03839355 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
NCT02415400 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
NCT02960126 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Apixaban in Recent Acute Coronary Syndrome
NCT00313300 ·Status: COMPLETED ·Phase: PHASE2
-
Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)
NCT03596502 ·Status: COMPLETED
-
Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data
NCT04593056 ·Status: COMPLETED
-
NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH
NCT02998905 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
NCT00580216 ·Status: TERMINATED ·Phase: PHASE3
-
Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
NCT02565693 ·Status: COMPLETED ·Phase: PHASE2
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4
-
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority
NCT02832531 ·Status: WITHDRAWN ·Phase: PHASE3
-
INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
NCT02832544 ·Status: COMPLETED ·Phase: PHASE3
-
Replication of the ARISTOTLE Anticoagulant Trial in Healthcare Claims Data
NCT04593030 ·Status: COMPLETED
-
Apixaban in Patients With Left Ventricular Thrombus
NCT05208398 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Pattern of Oral Anticoagulants (OAC) in Japan
NCT02982863 ·Status: COMPLETED